Lexaria Bioscience Corp.
Biotech firm with patented technology improving oral drug delivery and absorption.
LEXX | NDAQ
Overview
Corporate Details
- ISIN(s):
- US52886N4060 (+1 more)
- LEI:
- Country:
- United States of America
- Address:
- 100 - 740 MCCURDY ROAD, KELOWNA
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Lexaria Bioscience Corp. is a biotechnology company focused on its patented drug delivery technology platform, DehydraTECH™. This technology improves the way active pharmaceutical ingredients (APIs) and other bioactive molecules enter the bloodstream through oral delivery. DehydraTECH enhances bio-absorption and has demonstrated superior pharmacokinetics across a broad range of small and large molecules, including GLP-1 peptide drugs. The platform is applicable to various product formats such as tablets, capsules, and oral suspensions. The company's technology is protected by a robust intellectual property portfolio with over 50 patents granted internationally.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Lexaria Bioscience Corp. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Lexaria Bioscience Corp.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Lexaria Bioscience Corp. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
